Metabolon at ADPD 2025 – International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders
Dates: April 1–5, 2025
Location: Vienna, Austria (Hybrid Conference)
Visit the Official Event Website
Booth Location: 89
Join Metabolon at ADPD 2025
Metabolon is attending ADPD 2025, the largest international event showcasing advances in Alzheimer’s, Parkinson’s, and related neurodegenerative diseases. This conference brings together leading neuroscientists, clinicians, and industry professionals to discuss breakthroughs in biomarker discovery, disease mechanisms, and therapeutic development.
Where to Find Metabolon at ADPD 2025
You can find Metabolon exhibiting at booth location 89, where several of the Metabolon team will be happy to demonstrate our metabolomics and bioinformatics solutions with you and discuss our experiences working in neurodegenerative disease research.
About ADPD 2025
The ADPD International Conference is a leading platform for sharing cutting-edge research in neurodegenerative diseases, providing an interdisciplinary space for scientists and industry leaders to exchange insights and foster collaborations. The conference covers the latest discoveries in molecular pathways, early diagnostics, clinical trials, and disease-modifying treatments for Alzheimer’s, Parkinson’s, and other related disorders.
Scientific Themes and Program Highlights
- Neurodegenerative Biomarkers – Advancements in blood, CSF, and imaging biomarkers for early detection and disease progression monitoring.
- Molecular Mechanisms of Disease – Insights into protein misfolding, mitochondrial dysfunction, and neuroinflammation.
- Metabolomics in Neurological Disorders – The role of metabolism in disease progression, diagnosis, and therapeutic response.
- Gene Therapy and Drug Discovery – Innovations in therapeutic strategies for modifying disease pathology.
- Multiomics and Systems Biology – Integration of metabolomics, proteomics, and genomics to advance precision medicine in neurology.
Why Metabolon is Attending ADPD 2025
Metabolon is returning to ADPD 2025 after a high-impact scientific program at ADPD 2024 in Lisbon, Portugal. There has never been a better time to generate high-quality, actionable insights from metabolomics data, and neurological research is at the forefront of new, metabolite-led biological discoveries.
Advancements in metabolite identification, pathway mapping, and data integration have made metabolomics an essential tool for understanding neurodegenerative diseases. Metabolon provides best-in-class metabolomics solutions, delivering:
- Comprehensive data generation and validation through targeted and untargeted metabolomics.
- Seamless integration of metabolomics and other omics data within our Integrated Bioinformatics Platform.
- Actionable insights for biomarker discovery, drug development, and patient stratification in Alzheimer’s and Parkinson’s research.
- High-quality, reproducible metabolomics data supporting multiomics research and clinical translation.
By leveraging our global expertise, validated methodologies, and extensive publication record, Metabolon’s multiomics-driven approach is a game-changer for neurodegenerative disease research.
Meet the Metabolon Team at ADPD 2025
Our team of scientific and business leaders will be available for discussions on how metabolomics is advancing neurodegenerative disease research:
- Dr. Patrick Arnott, Sales & Business Development Director, Metabolon
Patrick has a strong background in commercializing life sciences solutions, with expertise in DNA nanotechnology, CRISPR, vaccines, and cell & gene therapy research. His experience in biotech consulting, business strategy, and process development makes him a valuable resource for translating research needs into metabolomics-driven solutions.
Connect with Patrick on LinkedIn
- Simone de Faria Maraschin, PhD, EMEA & APAC Sales Director, Metabolon
Simone has over 20 years of experience in biological research, project management, and scientific solutions development. With a PhD from Leiden University, she leads Metabolon’s EMEA and APAC Sales Organization, providing strategic insights into metabolomics applications in neurological disease research.
Connect with Simone on LinkedIn
- Dr. Natasa Giallourou, Metabolomics Scientist, Metabolon
Natasa is a field metabolomics scientist specializing in biopharma and academic applications of metabolomics. She has a PhD from the University of Reading, with expertise in multiomics data integration, biomarker discovery, and metabolic phenotyping for complex diseases.
Connect with Natasa on LinkedIn
- Kieran Jones, Strategic Account Manager, Metabolon
Kieran brings extensive experience in biopharma, analytical sciences, and drug discovery. His expertise in immunoassay-based analytical method development, biomarker validation, and multiomics integration makes him a key resource for researchers looking to leverage metabolomics for therapeutic development.
Connect with Kieran on LinkedIn
- Michael Irwin, VP Sales, Metabolon
Michael leads Metabolon’s global sales team, supporting life sciences organizations in leveraging metabolomics for breakthrough discoveries in neurological research. Michael previously lead Olink’s Sales and Marketing departments before joining Metabolon to support the growing demand for metabolomics data insights.
Connect with Michael on LinkedIn
